drugset
Drugs / viral specific cytotoxic t-lymphocytes
last change Nov 2018 re-read 3 minutes ago

viral specific cytotoxic t-lymphocytes

Developed for
cytomegalovirus infection
Investigated by
Children's Hospital Los Angeles · Children's Hospital of Philadelphia · Indiana University · Johns Hopkins University · Medical College of Wisconsin · Nationwide Children's Hospital
+3 more · New York Medical College · University of California, San Francisco · Washington University School of Medicine

Trials 1

today NCT03266640 · Ph 2
201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03266640 Nov 2018 → Dec 2026 expected cytomegalovirus infection, immunodeficiency disease New York Medical College Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as viral specific cytotoxic t-lymphocytes ClinicalTrials.gov intervention name — accepted as the source's own label NCT03266640 ↗